Fortis Healthcare to Install Indias First Upright Proton Therapy System Advancing Precision Cancer Care

Fortis Healthcare to Install India’s First Upright Proton Therapy System, Advancing Precision Cancer Care

- The advanced MEVION S250-FIT™ Proton Therapy System™, featuring Leo Cancer Care’s 
Marie® upright positioning technology, will be installed at Fortis Memorial Research Institute, Gurugram -

New Delhi, September 8, 2026: Fortis Healthcare, part of the IHH Healthcare group, today announced 
plans to install the MEVION S250-FIT™ Proton Therapy System™ from Mevion Medical Systems at 
Fortis Memorial Research Institute (FMRI), Gurugram, its flagship quaternary-care hospital and a 
leading centre for comprehensive oncology and precision cancer care.

Featuring Leo Cancer Care’s Marie® upright patient positioning and imaging solution, along the 
treatment planning software RayStation®, by RaySearch Laboratories, the system will make Fortis the 
first healthcare provider in India planning to introduce upright proton therapy. It will also be the first 
Leo Cancer Care system installed in the country.

Subject to applicable regulatory approvals and completion of the necessary site preparations, the 
installation will represent an important advancement in India’s precision-oncology capabilities and 
expand access to highly targeted radiation treatment for selected adult and paediatric cancers.

Unlike conventional radiation therapy, which uses X-rays that continue to release radiation as they pass 
through the body, proton therapy can deliver the prescribed dose directly to the tumour with minimal 
exit radiation. This enables doctors to target cancer more precisely while reducing radiation exposure 
to surrounding healthy tissues and critical organs.

This precision can be particularly valuable in treating selected paediatric cancers and tumours located 
close to sensitive structures such as the brain, spinal cord, heart and lungs.

The new system combines an ultra-compact proton accelerator and fixed-beam delivery architecture 
with a 360-degree upright patient-positioning platform and integrated CT imaging. Instead of rotating 
a large treatment gantry around a patient lying on a table, the technology holds the patient in a seated 
position in front of a fixed proton beam.

Treating patients in an upright position may provide a more natural and comfortable experience for 
those who find it difficult to lie flat because of pain, breathing difficulties, limited mobility, or anxiety. 
Its open design may also reduce feelings of confinement and allow patients to remain more engaged 
with the clinical team during positioning and treatment.

The platform integrates upright CT imaging at the treatment position, enabling clinicians to image, 
position and treat patients in the same orientation. This can support accurate alignment, anatomical 
consistency, and advanced image-guided treatment workflows.

These advanced workflows are supported by RayStation a leading software for proton treatment 
planning, combining advanced technologies in one system. With a long history of pioneering 
innovation in particle therapy and ongoing investments in research and development, RaySearch is 
dedicated to continuously advancing RayStation to meet the evolving needs of proton therapy centers 
worldwide.

The system’s compact architecture will enable installation within an existing building at FMRI, where 
accommodating a conventional gantry-based proton therapy system would require substantially 
greater space and infrastructure. By reducing the construction requirements traditionally associated 
with proton therapy, the technology offers a practical pathway for introducing this advanced treatment 
capability within an established cancer centre.

FMRI is home to the Fortis Cancer Institute, a comprehensive oncology centre bringing together 
medical, surgical and radiation oncology, precision diagnostics, and multidisciplinary clinical expertise. 
The planned installation will further strengthen its advanced and personalised cancer-care capabilities.

Dr Ashutosh Raghuvanshi, Managing Director & CEO, Fortis Healthcare, said, “India’s rising cancer 
burden calls for a fundamental shift towards earlier diagnosis, greater treatment precision, and wider 
access to advanced oncology care. As healthcare providers, our responsibility is to build an ecosystem 
in which globally advanced technologies are integrated with strong clinical expertise and made accessible to more patients. The planned installation of the MEVION S250-FIT™ Proton Therapy System at FMRI reflects this vision. Beyond introducing India’s first upright proton therapy system, it represents 
an important step towards strengthening the country’s precision-oncology capabilities, addressing 
infrastructure barriers and building a more patient-centric and future-ready cancer-care ecosystem.”

Stephen Towe, Chief Executive Officer, Leo Cancer Care, said, “Fortis Healthcare’s decision is a 
landmark moment for Leo Cancer Care and for upright radiotherapy. India is an important new territory 
for us, and we are proud that our first system in the country will be delivered in partnership with Fortis 
and IHH Healthcare.

This project captures exactly why upright radiotherapy matters. By eliminating the need for a large 
rotating gantry, the MEVION S250-FIT can bring proton therapy into an existing building where no 
other proton system could be accommodated. Together, we are overcoming a major infrastructure 
barrier and creating the opportunity for more patients to access proton therapy.”

Conventional proton therapy facilities typically require substantial space, construction, and supporting 
infrastructure. The planned installation at FMRI is expected to expand access to advanced proton 
treatment in India and establish a foundation for the wider adoption of upright radiotherapy across 
the region.

The installation at Fortis Memorial Research Institute, Gurugram, is subject to applicable regulatory 
approvals and completion of the necessary site preparations.

About Leo Cancer Care
Leo Cancer Care is challenging the conventional delivery of radiotherapy through an upright approach that places the patient at the centre of treatment. Its Marie® solution combines 360-degree upright patient positioning with integrated CT imaging and can be paired with a fixed particle beam. By removing the need for a large rotating gantry, the technology is designed to reduce the space and infrastructure required for advanced radiotherapy while supporting a more natural and patient-focused treatment experience.
For more information, visit leocancercare.com